One individual with SLE who was positive for antiphospholipid antibodies and treated with 4 mg baricitinib developed a deep vein thrombosis (accounting for 1% of patients treated with 4 mg baricitinib). update of important findings about kidney diseases (including diabetic nephropathy, lupus PS-1145 nephritis, and vasculitis, i.e., vasculitis with antineutrophilic cytoplasmic antibodies). New disease targets, … Continue reading One individual with SLE who was positive for antiphospholipid antibodies and treated with 4 mg baricitinib developed a deep vein thrombosis (accounting for 1% of patients treated with 4 mg baricitinib)